Generative AI in Health Care: From Proof of Concept to Transformational Impact
Register now to get your free report!
The health care sector is on the cusp of a GenAI revolution. A recent survey of the NEJM Catalyst Insights Council, in collaboration with Deloitte, indicated that 67% of respondents expect moderate to significant change within two years, rising to nearly 90% long-term. This technology is being used for patient communication through chatbots and virtual assistants, care coordination by predicting patient outcomes and potential complications, and clinical documentation with ambient listening tools. New analysis from Deloitte suggests that organizations that strategically embrace GenAI with robust governance will lead this transformation. Is your organization ready?
Download this free report today.
Brought to you as a professional courtesy by Deloitte’s Life Sciences & Health Care Practice.
About Deloitte’s Life Sciences & Health Care Practice
Throughout the health ecosystem, you’ll find courageous and inspiring people who are committed to driving transformation and leading a well-being revolution. Where you find innovators committed to sustainable progress, you’ll find Deloitte’s Life Sciences & Health Care practice. Our leaders work side-by-side to orchestrate and deliver on the business of science and health. We bring trusted, flexible approaches that foster innovation, harness new technologies, and formulate consumer-driven strategies to engineer a digitally enabled future of health – starting today. For more insights from Deloitte’s Life Sciences and Health Care practice, visit www.deloitte.com/us/lifesciencesandhealthcare and www.deloitte.com/us/industry-advantage.
